Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

OTC Decisions August-October: More Providers Enter Diclofenac, Lansoprazole, Loratadine Markets

Nov 03 2020

• By Malcolm Spicer

OTC Regulatory Decisions Tracker US

Related Content

Divided FTC Okays Mylan-Upjohn Merger But Election Outcome Could Impede Future Deals

Oct 31 2020

Perrigo Has Approval For Copy Of OTC Voltaren Arthritis Relief Before GSK Launches The Brand

Apr 07 2020

With Pataday Extra Strength, Alcon Eyes Consumers Looking For OTC 24-Hour Eye Allergy Remedy

Jul 13 2020

US OTC Switch Drought Ends: FDA Approves GSK Arthritis Gel, Alcon Allergy Eye Drops

Feb 17 2020

Perrigo Feeds OTC Brand Play With Prevacid As GSK Thins Consumer Lineup

Sep 05 2019

In Latest US OTC Switch, Ivermectin 0.5% Lice Treatment Becomes Fully Nonprescription

Oct 27 2020

Additional Topics

Europe International India Asia Pacific China United Kingdom United States OTC Drugs FDA Prescription To OTC Switch Advertising, Marketing & Sales Commercial Companies Drug Approval Standards Ingredients Manufacturing Policy Regulation Consumer

More from Rx-to-OTC Switch

More from Health

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window